TETRAULT LYNN A. 4
4 · NEOGENOMICS INC · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
NEO Director Lynn A. Tetrault Sells 5,307 Shares
What Happened
- Lynn A. Tetrault, a director of Neogenomics, reported the sale of 5,307 shares of NEO common stock on June 9, 2026. The shares were disposed at $11.29 each, for total proceeds of $59,916. This was a sale (routine insider disposition), not a purchase.
Key Details
- Transaction date: 2026-06-09
- Transaction type/code: Sale (S) — reported as open-market/private sale
- Price per share: $11.29
- Total proceeds: $59,916
- Shares owned after transaction: Not disclosed in the provided filing excerpt
- Footnote: F1 — once vested, the shares of common stock are not subject to expiration
- Filing timeliness: Report filed on 2026-06-11 (filed within the typical two-business-day Form 4 window)
Context
- Sales by directors can be routine (diversification, liquidity, tax planning) and do not necessarily indicate a change in outlook. Because this filing reports a sale rather than a purchase, it is less commonly interpreted as a bullish signal.
Insider Transaction Report
Form 4
TETRAULT LYNN A.
Director
Transactions
- Sale
Common Stock
2026-06-09$11.29/sh−5,307$59,916→ 91,422 total
Holdings
- 7,000(indirect: By IRA)
Common Stock
- 2,136
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (2,136 underlying) - 3,448
Stock Option (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - 3,714
Stock Option (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - 972
Stock Option (Right to Buy)
Exercise: $41.76From: 2022-10-11Exp: 2028-10-11→ Common Stock (972 underlying) - 13,882
Stock Option (Right to Buy)
Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying) - 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 16,107
Stock Option (Right to Buy)
Exercise: $7.28From: 2026-06-01Exp: 2035-06-01→ Common Stock (16,107 underlying) - 11,069
Stock Option (Right to Buy)
Exercise: $10.52From: 2027-06-01Exp: 2036-06-01→ Common Stock (11,069 underlying) - 15,970
Restricted Stock Unit
[F1]Exercise: $0.00From: 2027-06-01→ Common Stock (15,970 underlying)
Footnotes (1)
- [F1]Once vested, the shares of common stock are not subject to expiration.
Signature
/s/ Ali Olivo, Attorney-in-Fact|2026-06-11